Exporting Cannabis to the EU
In a previous post, we discussed how some Canadian producers are selling excess inventory to export markets, including Europe.
In “The Europe Medical Cannabis Market,” Market Data Forecast reports, “The medical cannabis market in Europe is expected to grow from USD 4.96 billion in 2022 to USD 13.37 billion by 2027, growing at a CAGR [compound annual growth rate] of CAGR 21.96% from 2022 to 2027.”
Based on that report, Europe appears to be a significant marketplace for cannabis. But to sell into that market, the exporter must meet the region’s standards. In the case of Europe, those standards include the European Union’s Good Manufacturing Practices, referred to as EU GMP.
In their article, “A Look at Canadian Cannabis Exports,” published in 2021, The Business of Cannabis reported one reason why exports jumped in 2020. “In Canada, more cultivators gained the European Union’s Good Manufacturing Practices (EU GMP) certification, allowing them to export to that continent. More than a dozen Canadian LPs now have EU GMP certified facilities.”
Meeting EU GMP standards is critical for exporting into the European marketplace. But what is EU GMP and how does it differ from the standards Canadian companies already meet?
Health Canada requires that Canadian licensed producers comply with Good Production Practices or GPP standards. If you are a licensed producer in Canada, you are already familiar with GPP. If not, these standards are explained on the Health Canada website.
Essentially, GPP requires that cannabis businesses have appropriate procedures for all activities related to producing a product that is safe for public consumption. GPP mandates that systems be in place to ensure quality and traceability.
Good Manufacturing Practices, GMP, takes GPP further including requiring more stringent testing.
The Foundation of Cannabis Unified Standards (FOCUS) states, “GMP is the proactive part of quality assurance. It is designed to minimize the risks involved in all steps of the manufacturing process. A basic tenant of GMP is that quality cannot be tested into a product. It must be built into each batch of product during all stages of the manufacturing process.”
Originally designed for pharmaceutical products, GMP can be applied to any production process and is a requirement for those wishing to market medical cannabis in Europe.
The EU GMP standards are complex, and the information can be difficult to navigate, especially how it applies to cannabis.
But the Canadian government has published guidelines designed to help manufacturers meet GMP standards. Their guidance document has been written “with a view to harmonize with GMP standards from: the World Health Organization (WHO); the Pharmaceutical Inspection Cooperation/Scheme (PIC/S); the International Council on Harmonisation (ICH); the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); other regulatory agencies in other countries.”
While the EU is not mentioned specifically, these Canadian standards are a good starting point for cannabis companies considering exporting into other markets. These guidelines will help producers understand what is required and can be used as a stepping stone toward EU GMP certification.
According to the media, the EU standards are stringent, and certification can be time consuming and costly. But with a market as large as Europe, Canadian companies are in a position to benefit from the opportunities that an EU GMP certificate can offer.
To access the resources quoted here, use the following links:
- https://businessofcannabis.com/a-look-at-canadian-cannabis-exports/
- https://www.marketdataforecast.com/market-reports/europe-medical-cannabis-market
- https://www.focusstandards.org/gmp-cannabis-industry/
- https://www.gmp-compliance.org/guidelines/gmp-guidelines
- https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-0001/document.html
Can Canadian Producers Export Excess Supply?
With media reporting oversupply challenges in the Canadian cannabis industry, can producers turn to export markets to sell their inventory? The answer might be yes. As countries around the world legalize cannabis, new opportunities are emerging for producers in Canada.
Canadian companies have been exporting cannabis for several years already. In fact, back in June 2020, MJBizDaily published a two-part article on Canada’s export of medical cannabis during 2019. Part 1 was titled, “Canada exported record amount of dried cannabis in 2019…” Part 2 reported, “Canadian exports of medical cannabis oil jumped fivefold in 2019.”
Canadian Regulatory Review reported in September of 2020 that the Canadian government had even become supportive of cannabis exports. “On the export side, and to further bolster trade, as of January 2020, the federal government through Canada’s Trade Commissioner Service extended trade commissioner services for Canadian cannabis companies exporting cannabis for medical and scientific purposes.”
A few months after that article, in April 2021, Prohibition Partners released a report called “Revealed: The Canadian Cannabis Export Market for 2020.” The report notes that the largest export markets for Canada at the time were Germany, Australia, Israel and the United Kingdom. “…new data shows a huge increase in the exports of cannabis from the country in 2020, as well as a changing network of countries that are importing from established producers in Canada.”
In May of that same year, Business of Cannabis took “A look at Canadian cannabis exports,” noting that “Dried cannabis flower and cannabis oil exports more than doubled in 2020, while imports dropped to virtually zero…”
An article titled, “How Canada’s Oversupply of Cannabis Is an Export Opportunity,” was published in October of 2022 by Canadian Cannabis Exchange. “As the demand for cannabis legalization increases internationally, Canada has the opportunity to become the world leader in cannabis exports… The European Union is proving to be a lucrative market for Canadian exports.”
To read the full articles quoted here, visit the following links:
- https://mjbizdaily.com/canada-exported-record-amount-of-dried-cannabis-in-2019/
- https://mjbizdaily.com/canadian-exports-of-medical-cannabis-oil-jumped-fivefold-in-2019/
- https://www.canadaregulatoryreview.com/international-trade-in-cannabis-international-and-domestic-regulatory-developments/
- https://prohibitionpartners.com/2021/04/30/revealed-the-canadian-cannabis-export-market-for-2020/
- https://businessofcannabis.com/a-look-at-canadian-cannabis-exports/
- https://canadiancannabisx.com/how-canadas-oversupply-of-cannabis-is-an-export-opportunity/
Health Canada Seeks Your Feedback from March 25 to May 24, 2023
In relation to a consultation on potential amendments to the Cannabis Regulations, Health Canada is seeking feedback and comments on potential amendments to the Cannabis Regulations.
The aims of the consultation include clarifying existing requirements, eliminating regulation inefficiencies and duplications and reducing administrative and regulatory burdens, and Health Canada is seeking input from:
- cannabis industry stakeholders
- public health stakeholders, non-governmental organizations
- researchers and research or academic institutions
- First Nations, Inuit and Métis partners and organizations
- law enforcement
- provincial, territorial and municipal governments
For more information including how you can provide feedback until May 24, 2023, visit:
https://www.canada.ca/en/health-canada/programs/consultation-potential-amendments-cannabis-regulations.html
What to Expect from the Cannabis Act Review
Since the announcement of the Cannabis Act review, people are speaking out about what they hope to see from reviewers.
The review was initially planned to begin in 2021 and look at the public health implications of the legalization of cannabis in Canada.
The CBC reported that the government delayed the start of the review to expand the scope. “The review mandate has been expanded to include an examination of the social and environmental effects of the Cannabis Act, the impact of legalization and regulation of medical cannabis and the impact on racialized communities and women.”
Read more here: https://www.cbc.ca/news/politics/public-health-cannabis-mandated-eview-1.6591442
An article in The Globe & Mail stated that “For George Smitherman, the chief executive officer of the Cannabis Council of Canada, the national industry association, the announcement comes at a critical time. Companies continue to face pressure from the illicit market, as well as excise taxes, provincial distributor markups and regulatory fees.”
Read more here: https://www.theglobeandmail.com/business/article-health-canada-cannabis-act-review/
The Toronto Star notes that the pot sector wants packaging changes and financial relief from the review. “The industry is frustrated the review’s launch arrived a year later than mandated but is still hoping it can result in enough tweaked restrictions to make cannabis distribution easier, draw in new customers and prevent more staffing and facility cuts.”
Read more here: https://www.thestar.com/news/cannabis/2022/09/22/pot-sector-wants-packaging-changes-financial-relief-from-cannabis-act-review.html
The review is expected to be completed in 18 months, and government officials say that it will consider health issues as well as financial, tax, regulatory and criminal-justice matters.
Media Marks the Fourth Anniversary of Cannabis Legalization in Canada
Yesterday, October 17, 2022, was the fourth anniversary of the legalization of cannabis in Canada.
Canada legalized cannabis on October 17, 2018. Since then, there have been many changes to the cannabis landscape, but some say we need even more reform.
The media took the opportunity to mark the day with reviews of the progress, criticisms of the process and calls for improvement.
Stratcann, an online news publication covering the evolution of the legal cannabis industry in Canada and around the world, chronicled Canadian legalization.
Read the article here:
https://stratcann.com/insight/four-years-later-following-canadas-path-to-legalizing-cannabis/
The Toronto Sun claimed, “Still much to iron out on fourth anniversary of Canada’s legalization of cannabis.”
Read the article here:
https://torontosun.com/news/still-much-to-iron-out-on-fourth-anniversary-of-canadas-legalization-of-cannabis
MJBizDaily, a news source for the cannabis industry in the US and Canada, published that “Canadian marijuana businesses pitch reform on legalization’s 4th anniversary.”
Read the article here:
https://mjbizdaily.com/canadian-cannabis-businesses-pitch-reform-on-legalization-4th-anniversary/
The Toronto Star declared that Canada’s cannabis producers say they’re in crisis.
Read the article here:
https://www.thestar.com/news/canada/2022/10/17/canadas-cannabis-producers-say-theyre-in-crisis-heres-what-theyre-asking-the-government-to-do.html
B.C. Enables Cannabis Farm-to-gate Sales
The Province of British Columbia announced last week that it will introduce a new cannabis retail licence that will allow eligible federally licensed cannabis producers to sell non-medical cannabis products from stores located at their cultivation site.
The producer retail store (PRS) license is expected to go into effect on November 30, 2022.
Standard cultivators, micros and nursery licence-holders will be eligible to apply through the Liquor and Cannabis Regulation Branch’s (LCRB) liquor and cannabis licensing portal.
The media release published on the Province’s website reads, “This licence was created as part of the Province’s commitment to enable farm-to-gate cannabis sales in British Columbia… This launch follows the recent opening of the first farm-gate cannabis facility in B.C. in Williams Lake, which was a result of the government-to-government agreement between the Province and Williams Lake First Nation.”
B.C. currently has 212 federally licensed cannabis producers, which includes 74 micro-producers.
To read the full media release visit: https://news.gov.bc.ca/releases/2022PSSG0061-001490
Information about cannabis regulation in B.C.: https://www.cannabis.gov.bc.ca
Information about the Buy Legal campaign: https://www2.gov.bc.ca/gov/content/safety/public-safety/cannabis/buy-legal
Licensed cannabis producers and retail stores in B.C. interested in participating in direct delivery can find information on the program’s website:
https://www.bcldbcannabisupdates.com/LDBDirectDeliveryProgram
Information about the BC Indigenous Cannabis Product (BCICP) program: https://www.bcldbcannabisupdates.com/BCICP
Government of Canada Launches Cannabis Act Review
On September 22, 2022, the Government of Canada announced the launch of a legislative review of the Cannabis Act.
The announcement stated, “Parliamentarians recognized the need for an early assessment of the Government’s new approach to cannabis control, and included a provision requiring a review in the Act. The review will help ensure that the Act adapts to the current situation and continues to meet Canadians needs and expectations.”
An independent panel of experts will lead what is being called a credible and inclusive review. “The Panel will provide independent, expert advice to both Ministers on progress made towards achieving the Act’s objectives, and will help identify priority areas for improving the functioning of the legislation.”
In conjunction with the legislative review, an online engagement process has been launched.
All Canadians are invited to read Taking Stock of Progress: Cannabis Legalization and Regulation in Canada.
Canadians are also encouraged to share their views via the online questionnaire or through written feedback until November 21, 2022.
Take the survey here: https://ca1se.voxco.com/SE/?st=3KoT2Xgsv4uHJF2%2F0i%2F7oo5IS3ATejUCjIjdJ4lUsME%3D&lang=en
You can also read the original announcement on the Government of Canada website.
Micro licences take off in Quebec
According to a recent post at the cannabis news website, Stratcann, Quebec has seen more new micro licences in 2022 than any other province so far this year.
The CEO of the Association québécoise de l’industrie du cannabis (AQIC), Pierre Leclerc, says believes the recent increase may be a reflection of the maturing market.
“I think Quebec entrepreneurs sat back a little and watched how the market would play out… building a business model around the micro licence production is something that makes sense in Quebec.”
Read the full article here: https://stratcann.com/news/micro-licences-taking-off-in-quebec/
For more information on how AirMed supports micro growers and processors, visit our Software page.
Canadian Greenhouse Conference 2022: Oct 5-6 Niagara Falls
As Canada’s foremost event for commercial greenhouse flower, vegetable, cannabis, berry and nursery growers, the Canadian Greenhouse Conference is the ultimate connection point for growers, suppliers and research partners.
The 2022 Canadian Greenhouse Conference will take place in-person at the Niagara Falls Convention Centre in Niagara Falls, Ontario on October 5 and 6.
The CGC is excited to continue its 40-year tradition of supporting professional Canadian growers; offering two days of informative, motivating sessions and a large trade show featuring 200+ exhibitors.
For more information visit: https://www.canadiangreenhouseconference.com/
Canadian cannabis sales projected to double over next five years
A “Cannabis Canada Weekly” column published on BNN Bloomberg in March 2022 reports that Canadian cannabis sales are expected to double to $8.8B over next five years.
The article refers to a report published by the market researchers at Brightfield Group and notes, “The pace of sales in Canada’s cannabis market may be slowing down, but it is still expected to double over the next five years, according to a new report.”
Read the article by visiting BNN Bloomberg: https://www.bnnbloomberg.ca/cannabis-canada-weekly-market-expected-to-double-by-2027-pot-stocks-up-on-u-s-legalization-hopes-1.1743189
Health Canada authorizing dried and fresh cannabis sales to licensees
Beginning April 19, 2022, existing holders of micro and standard cannabis licenses in Canada will be granted authorization to sell dried and fresh cannabis products. A notification went out to existing license holders at the end of March that this regulatory change will allow them to sell dried or fresh cannabis products to provincial wholesalers. Prior to this, a sales amendment was required to sell those products.
“Initial licensing came with sales conditions, and the amendment application process could take months,” said Justin Hearn, president and CEO of AirMed Canada Systems, “These changes are designed to reduce the regulatory burden for licensees and help them get their products to market more quickly. We expect this to be especially significant for our micro clients who want to carry out farmgate sales.”
Health Canada will automatically reissue licenses with amended conditions over the next three months. Those who had already applied for an amendment for dried and fresh cannabis sales will be prioritized in the process. Following the regulations, licensees will still need to submit a Notification of New Cannabis Product (NNCP) 60 days in advance of the sale of any new product.
This modification to the license program has been implemented as part of Health Canada’s efforts to improve the cannabis licensing process. According to the notification, “The decision is based on the lower risk associated with producing dried and fresh cannabis products.”
Note that the change applies only to dried and fresh cannabis products. Other products, such as edibles and vape cartridges, are not included in the sales amendment. Licensees planning to sell those products must still apply to Health Canada for a sales amendment.
“While these changes do not apply to the sale of extracts and edibles, it is certainly a step in the right direction,” said Hearn. “We expect edibles and extracts to play a significant role in cannabis sales in the future and have already added support in AirMed for these classes of cannabis.”
For more information about cannabis in Canada, visit: https://www.canada.ca/en/services/health/campaigns/cannabis/industry.html
For information on how AirMed manages the sale of cannabis products for licensees, visit: https://airmedcloud.com/software/#sell
Report says Cannabis Contributed $43.5 Billion to Canada’s GDP since legalization
The industry analysts at Deloitte Canada have published an annual report on the Canadian cannabis industry. Posted February 1, 2022, the report is titled, “An industry makes its mark: the economic and social impact of Canada’s cannabis sector.”
The authors of the report wrote, “Canada’s cannabis industry is generating billions for the country’s economy and government coffers… In the span of three years, the Canadian cannabis sector has found its footing and emerged as a thriving new source of economic growth, creating and supporting tens of thousands of jobs in communities countrywide.”
The report is based on a study that uses an input-output methodology to estimate the economic contributions of the Canadian cannabis sector.
To read more about this report visit: Deloitte Canada
To download the full report in PDF visit: An industry makes its mark
Deloitte Report Discusses Retail Cannabis Pricing Dynamics
With the help of BDSA and Hifyre, the analysts at Deloitte Canada examined consumer sales data alongside Deloitte’s recent survey of cannabis consumer preferences. The goal? To better understand pricing dynamics in both the Canadian and American adult-use cannabis markets.
“We discovered some fundamental similarities between cannabis and consumer packaged goods (CPG) markets—and some key differences.”
This report, titled “Price. It’s Complicated,” gives a close look at how cannabis behaves like a typical CPG (consumer packaged goods) market and the dynamics at play when it doesn’t. The report outlines some recommendations for companies looking to stay competitive in the challenging environment of this young industry.
To read more about this report visit: Deloitte Canada
To download the full report in PDF visit: Price. It’s Complicated.
AirMed is still 100% Canadian owned
As US corporations buy up seed-to-sale software companies in Canada, AirMed is still 100% Canadian owned.
AirMed was created in 2014 to help Canadian licensed producers meet compliance at all levels of government. Continuously innovating since then, we believe that building a culture of quality is an important part of our customers’ success. This commitment to quality is why a growing list of cultivators, nurseries, processors, manufacturers, and dispensaries use AirMed.
We rely on industry requirements and customer feedback to drive AirMed development, rather than investor pressure. We encourage our users to tell us what matters most to them in a cannabis management system. This feedback helps guide us in adapting AirMed to improve efficiency, productivity and user experience.
Our goal is to provide a responsive solution that not only meets customer needs but anticipates them, regardless of the size or focus of your cannabis business. That has been our driving force for nearly eight years.
Contact AirMed for a demo today to see what homegrown can do for you. Call us at (877) 313-2442 or use the contact form in the footer of this page.
For more information about AirMed, visit our About page or our Frequently Asked Questions page. If you’d like to have a conversation about AirMed, please give us a call at 1-877-313-2442 or use one of the contact forms to start the ball rolling.
Canadian Greenhouse Conference 2021: Oct 6-7 Online
As Canada’s foremost event for commercial greenhouse flower, vegetable, cannabis, berry and nursery growers, the Canadian Greenhouse Conference is the ultimate connection point for growers, suppliers and research partners.
The 2021 Canadian Greenhouse Conference will offer a comprehensive on-line experience.
Speakers from across Canada and around the world bring expertise to our forum with live sessions, supplementary resources, and New Product Displays.
Sessions will be recorded and available on the virtual conference platform for 90 days. A full-access registration will be required to log on to the platform after October 7. Registration will remain open until January 6, 2022 and you may upgrade your basic registration at any time.
For more information visit: https://www.canadiangreenhouseconference.com/
Market Researcher Says Canadian Cannabis Industry Exceeded $2.6 billion in 2020
According to BDSA, a market research firm specializing in the cannabis industry, global cannabis sales exceeded $21 billion in 2020. Based in Boulder, Colorado in the United States, BDSA made this announcement on March 5, 2021 in a blog post highlighting statistics from a market forecast.
The post noted, “Legal cannabis sales in Canada totaled an estimated $2.6 billion in 2020 and are forecast to grow to nearly $6.4 billion in 2026, a CAGR of 16%… During the year, BDSA Retail Sales Tracking data in Alberta and British Columbia showed rapid growth in shares of new Cannabis 2.0 product categories.”
The market research company also made predictions for the market into 2026. “Global cannabis sales reached nearly $21.3 billion in 2020, an increase of 48% over 2019 sales of $14.4 billion. BDSA forecasts global cannabis sales will grow from $21.3 billion in 2020 to $55.9 billion in 2026, a compound annual growth rate (CAGR) of more than 17%. This growth is expected to be steady, roughly $6 billion annually.”
For more information visit:
https://blog.bdsa.com/cannabis-sales-in-2020
Cannabis Helps Canadian Agriculture Industry in 2020
According to the newspaper Moosejaw Today, Statistic Canada reported farm cash receipts of $16.7 billion increased 5.2 per cent in 2020 over 2019.
The newspaper article, published September 13, 2020, stated, “Without a 62 per cent increase — $685 million — in cannabis sales, farm cash receipts would have increased a mere .8 per cent… Led by surging cannabis sales, farm cash receipts in the first half of the year bucked the general decline caused by the coronavirus.”
To read the original article, visit: https://www.moosejawtoday.com/local-news/cannabis-steers-healthy-increase-in-agriculture-income-2706446
FREE Seed-to-sale Software Buyer's Guide
Record keeping is an essential part of Health Canada’s compliance regulations. From the advent of legal medical marijuana in Canada, legal producers of cannabis have been required to track every seed, rooted plant, gram of waste material, final dried product, as well as interactions with customers and more. Due to the sheer volume of information, an electronic record-keeping system is the only practical way to manage the process. The software industry has responded to this need by creating seed-to-sale management software systems designed to help producers track their operations and report to Health Canada to meet compliance.
To help you through the process of purchasing seed-to-sale software in the Canadian Cannabis marketplace, we've produced a 20-page guide that answers the following questions:
- What is a seed-to-sale software solution and why do I need one?
- How do I choose one software platform over another?
- What should I be looking for in the software?
- How does the software fit into my business?
- How is my data stored and secured?
- What happens if regulations change?
To download this guide courtesy of AirMed, please visit the following page and complete the form. Once you submit the form, you'll be able to download the guide.
AirMed Seed-to-Sale Software Buyer's Guide
Why you need seed-to-sale software for your cannabis business
Introduction
Seed-to-sale software tracks plant production from reproduction through growth, harvesting, drying, packaging, sales and distribution. Health Canada mandates record keeping for every part of the process, and Canadian seed-to-sale software applications focus on compliance built on Health Canada’s regulations.
Record keeping is an essential part of Health Canada’s compliance regulations. From the advent of legal medical marijuana in Canada, legal producers of cannabis have been required to track every seed, rooted plant, gram of waste material, final dried product, as well as interactions with customers. Due to the sheer volume of information, an electronic record-keeping system is the only practical way to manage the process. The software industry has responded to this need by creating seed-to-sale management software systems designed to help producers track their operations and report to Health Canada to meet compliance.
As a Health Canada applicant, you must specify the name of the software system you plan to use for record keeping and provide a summary of how the software program meets Health Canada’s requirements. As a result, you will need to make at least preliminary decisions into seed-to-sale management software early on in your application process.
This might seem like one more challenge along your path to becoming a licensed producer, but in reality, seed-to-sale software is designed to help you be successful.
Seed-to-sale software platforms should provide the electronic record keeping required to not only for you to meet compliance, but also to help you be successful in your business. From greenhouse to warehouse to customer, your software system should help you at every stage of your operation. Functionality for genetics tracking, inventory management, quality control, shipping & receiving, point-of-sale ecommerce, compliance auditing & reporting, and customer relationship management can provide you with full business administration.
Licensing
To do business in the cannabis industry in Canada, you must meet Canada’s licensing requirements. Currently there are several types of licenses for those wishing to carry out cannabis-related business in Canada.
- Standard Cultivation
- Micro-cultivation
- Nursery
- Standard Processing
- Micro-processing
- Sale
- Analytical Testing
- Research
Regardless of which class of license you get, you will be responsible for complying with all the regulations that apply from the various levels of government.
The Laws
The Cannabis Act
Formerly called the ACMPR, this act covers all aspects of cannabis in Canada from growing through processing to selling and more. It is the responsibility of the licensee/applicant to understand and meet all the requirements that apply to their business.
Other Federal Acts and Regulations
As a licensee or applicant, you are responsible for complying with requirements of other Canadian acts and regulations such as the Food and Drugs Act (FDA), the Pest Control Products Act, the Fertilizer Act, among others.
The Canada Revenue Agency
You’ll also need to meet requirements of the Canada Revenue Agency depending on which activities will be conducted with cannabis.
Provincial or Territorial Legislation
As a licensee or applicant, you’ll be responsible for complying with all applicable provincial or territorial laws and regulations (environmental laws, for example).
Municipal By-Laws
As well, you’ll need to deal with municipal by-laws such as zoning and building permits.
How can seed-to-sale software help?
From the advent of legal medical marijuana in Canada, legal producers of cannabis have been required to track every seed, plant, gram of waste material, final product, and more. Due to the sheer volume of information, an electronic record-keeping system is the only practical way to manage the process.
The software industry has responded to this need by creating seed-to-sale management software designed to help businesses meet compliance. Seed-to-sale software tracks growth, harvesting, processing, packaging, sales and distribution.
And some seed-to-sale software systems go beyond compliance to help businesses cultivate success with features and functionality to help fine-tune propagation, growth cycles, harvesting, production, derivatives, inventory, staffing, and product sales. AirMed is one of those. Wherever your business fits in the seed-to-sale supply chain, AirMed can help with both legal compliance and business acumen. For a free demo, call 877-313-2442, email info @ airmed.ca or fill out the form on our contact page.
For information on cannabis licensing in Canada visit: Cannabis Licensing Application Guide
For more information on purchasing seed-to-sale software, fill out a form to download our complete buyer’s guide: Seed-to-sale Software Buyer’s Guide
FREE Seed-to-sale Software Buyer's Guide
Record keeping is an essential part of Health Canada’s compliance regulations. From the advent of legal medical marijuana in Canada, legal producers of cannabis have been required to track every seed, rooted plant, gram of waste material, final dried product, as well as interactions with customers and more. Due to the sheer volume of information, an electronic record-keeping system is the only practical way to manage the process. The software industry has responded to this need by creating seed-to-sale management software systems designed to help producers track their operations and report to Health Canada to meet compliance.
To help you through the process of purchasing seed-to-sale software in the Canadian Cannabis marketplace, we've produced a 20-page guide that answers the following questions:
- What is a seed-to-sale software solution and why do I need one?
- How do I choose one software platform over another?
- What should I be looking for in the software?
- How does the software fit into my business?
- How is my data stored and secured?
- What happens if regulations change?
To download this guide courtesy of AirMed, please visit the following page and complete the form. Once you submit the form, you'll be able to download the guide.
AirMed Seed-to-Sale Software Buyer's Guide